ICU Medical (ICUI) revenue and earnings history
ICU Medical reported revenue of $2.23B for fiscal 2025 (year ended Dec 31, 2025), −6.3% on the year before, and net income of $732K.
Over 18 years, from fiscal 2007 to fiscal 2025, revenue grew at a compound rate of +14.7% a year.
Revenue and net income, 19 fiscal years
Annual figures, newest first
| Fiscal year | Revenue | Operating income | Net income | Operating cash flow | Capital expenditure | Free cash flow | Stock-based pay | Share buybacks | Dividends paid | Cash at year end | Total debt at year end | Report |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025ended Dec 31, 2025 | $2.23B−6.3% | $42.8M | $732K | $180M | $88M | $91.8M | $55.8M | $8.77M | — | $308M | $1.28B | 10-K |
| 2024ended Dec 31, 2024 |
The latest quarter, insider trades and fund moves: ICU Medical (ICUI) on OQRO.
Common questions
What was ICU Medical's revenue in fiscal 2025?
$2.23B for the year ended Dec 31, 2025, as reported in its 10-K filed Feb 19, 2026. That is −6.3% on fiscal 2024 ($2.38B).
How fast has ICU Medical's revenue grown?
From $188M in fiscal 2007 to $2.23B in fiscal 2025: a compound annual growth rate of +14.7% over 18 years. This is arithmetic on the filed figures and says nothing about the years ahead.
Where these figures come from
The SEC’s companyfacts data: every figure ICU Medical tagged in XBRL in its annual and quarterly reports since 2009 (some reports carry a few earlier years as comparatives). For each fiscal year OQRO keeps the twelve-month totals from the annual report and the cash and debt at year end, and when a later report restates a year, the later figure. Read again whenever the company files.
Figures are as reported, in US dollars, with no adjustment for acquisitions, disposals or one-off items. Earnings per share are left out because a stock split changes them between reports. This page describes the past and is not investment advice. No language model wrote it.
